Market Size of Vascular Injury Treatment Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR | 6.30 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | High |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Vascular Injury Treatment Market Analysis
The rising occurrences of vascular casualties are amongst the critical factors in the development of the worldwide market for vascular injury treatment. Less than 80 percent of cases of vascular injury is most commonly caused by penetrating trauma in the U.S. peripheral vascular injuries, which is due to increased use of endovascular interventions for medical and diagnostic purposes. Approximately 30% of vascular casualties are minimal-energy injuries (stab wounds and others) whereas high-energy injuries account for over 50% of vascular injuries.
The rise in the number of injuries owing to the increase in road casualties, sports injuries, wounds, and brutality further drives the market for the treatment of vascular injury. The high school athletes alone account for 2 million incidents, 50,000 visits to the doctor, and 30,000 hospital admissions in the U.S. each year, as per the CDC (Centers for Disease Control and Prevention), which in turn, is further boosting the vascular injury treatment market.
Vascular Injury Treatment Industry Segmentation
As per the scope of the report, vascular surgery is the intervention of venous, lymphatic systems, and arterial (excluding coronary arteries and intracranial) conditions of diagnosed patients. Patients seeking vascular surgery suffer from several common vascular diseases, such as lymphatic conditions, varicose veins, intermittent claudication, thoracic outlet syndrome, hyperhidrosis, artery malformations, and others.
| By Treatment | |
| Patch Angioplasty | |
| Lateral Arteriorrhaphy/ Venorrhaphy | |
| Bypass Graft | |
| Thrombectomy | |
| Extraanatomic Bypass | |
| Others |
| By Injury | |
| Thrombosis | |
| Contusion/Intimal Flap | |
| Laceration/Transection | |
| Spasm | |
| Aneurysm and Pseudoaneurysm | |
| Arteriovenous (AV) Fistula | |
| Others |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Vascular Injury Treatment Market Size Summary
The vascular injury treatment market is experiencing significant growth driven by the increasing incidence of vascular injuries, which are often a result of penetrating trauma and high-energy incidents such as road accidents and sports injuries. The market is further propelled by the rising prevalence of vascular diseases, including stroke, peripheral artery disease, and coronary heart disease, which necessitate advanced treatment options like bypass grafts. These treatments are crucial for improving blood flow and reducing complications associated with obstructive coronary artery disease. The demand for such interventions is expected to rise, particularly in regions with a growing geriatric population, such as North America, where the prevalence of vascular disorders is high.
North America is anticipated to maintain its leading position in the vascular injury treatment market due to the increasing prevalence of vascular diseases and a significant elderly population. The market is characterized by intense competition, with a few major players holding substantial market shares. These companies are actively engaging in collaborations and introducing new treatment options to strengthen their global market presence. The ongoing advancements in medical technology and the strategic initiatives by key players are expected to drive the market's growth trajectory over the forecast period.
Vascular Injury Treatment Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Rising Incidence of Vascular Injury Surgeries
-
1.2.2 Advancement in Technologies
-
-
1.3 Market Restraints
-
1.3.1 Side Effects Associated with the Vascular Injury Treatment
-
-
1.4 Porter's Five Force Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION
-
2.1 By Treatment
-
2.1.1 Patch Angioplasty
-
2.1.2 Lateral Arteriorrhaphy/ Venorrhaphy
-
2.1.3 Bypass Graft
-
2.1.4 Thrombectomy
-
2.1.5 Extraanatomic Bypass
-
2.1.6 Others
-
-
2.2 By Injury
-
2.2.1 Thrombosis
-
2.2.2 Contusion/Intimal Flap
-
2.2.3 Laceration/Transection
-
2.2.4 Spasm
-
2.2.5 Aneurysm and Pseudoaneurysm
-
2.2.6 Arteriovenous (AV) Fistula
-
2.2.7 Others
-
-
2.3 Geography
-
2.3.1 North America
-
2.3.1.1 United States
-
2.3.1.2 Canada
-
2.3.1.3 Mexico
-
-
2.3.2 Europe
-
2.3.2.1 Germany
-
2.3.2.2 United Kingdom
-
2.3.2.3 France
-
2.3.2.4 Italy
-
2.3.2.5 Spain
-
2.3.2.6 Rest of Europe
-
-
2.3.3 Asia-Pacific
-
2.3.3.1 China
-
2.3.3.2 Japan
-
2.3.3.3 India
-
2.3.3.4 Australia
-
2.3.3.5 South Korea
-
2.3.3.6 Rest of Asia-Pacific
-
-
2.3.4 Middle-East and Africa
-
2.3.4.1 GCC
-
2.3.4.2 South Africa
-
2.3.4.3 Rest of Middle East and Africa
-
-
2.3.5 South America
-
2.3.5.1 Brazil
-
2.3.5.2 Argentina
-
2.3.5.3 Rest of South America
-
-
-
Vascular Injury Treatment Market Size FAQs
What is the current Vascular Injury Treatment Market size?
The Vascular Injury Treatment Market is projected to register a CAGR of 6.30% during the forecast period (2024-2029)
Who are the key players in Vascular Injury Treatment Market?
Massachusetts General Hospital, Cleveland Clinic, Heidelberg University Hospital, Royal Berkshire NHS Foundation Trust and Mayo Clinic Health System are the major companies operating in the Vascular Injury Treatment Market.
